Skip to main content

Cytophenix completes pre-seed round

Just in

Bookmark

Save articles for future reference.

A Perth startup developing rapid tests which it says could detect antimicrobial resistance and find the best antibiotic for the patient's infection has received $1.3 million in pre-seed funding.

X

To read our articles you will need to either login or subscribe.